ALPS Advisors’s LeMaitre Vascular LMAT Stock Holding History

ALPS Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$444K	Buy	4,631 +45	+1%	+$4.61K	﹤0.01%	1023
2026 Q1	$501K	Sell	4,586 -405	-8%	-$38.6K	﹤0.01%	823
2025 Q4	$405K	Buy	4,991 +55	+1%	+$4.74K	﹤0.01%	887
2025 Q3	$432K	Buy	4,936 +664	+16%	+$59.3K	﹤0.01%	868
2025 Q2	$355K	Buy	4,272 +52	+1%	+$4.35K	﹤0.01%	859
2025 Q1	$354K	Buy	+4,220	New	+$393K	﹤0.01%	769
2022 Q1	–	Sell	-6,469	Closed	-$325K	–	908
2021 Q4	$325K	Buy	6,469 +130	+2%	+$6.72K	﹤0.01%	814
2021 Q3	$337K	Sell	6,339 -1,206	-16%	-$67.9K	﹤0.01%	812
2021 Q2	$460K	Hold	7,545	–	–	﹤0.01%	529
2021 Q1	$368K	Buy	+7,545	New	+$354K	﹤0.01%	535
2019 Q3	–	Sell	-12,775	Closed	-$357K	–	922
2019 Q2	$357K	Sell	12,775 -674	-5%	-$18.7K	﹤0.01%	766
2019 Q1	$417K	Buy	13,449 +249	+2%	+$6.64K	﹤0.01%	610
2018 Q4	$312K	Sell	13,200 -657	-5%	-$17.9K	﹤0.01%	782
2018 Q3	$537K	Buy	13,857 +1,434	+12%	+$51.7K	﹤0.01%	547
2018 Q2	$416K	Sell	12,423 -584	-4%	-$20.8K	﹤0.01%	746
2018 Q1	$471K	Buy	13,007 +700	+6%	+$24.2K	﹤0.01%	593
2017 Q4	$392K	Buy	12,307 +1	+0%	+$34	﹤0.01%	683
2017 Q3	$460K	Sell	12,306 -8,641	-41%	-$294K	﹤0.01%	648
2017 Q2	$654K	Buy	20,947 +54	+0.3%	+$1.56K	﹤0.01%	314
2017 Q1	$515K	Buy	+20,893	New	+$491K	﹤0.01%	380

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

ALPS Advisors's LMAT Position: Q2 2026 in Review

ALPS Advisors increased its LeMaitre Vascular (LMAT) stake by 0.98% in Q2 2026, buying an estimated $4.61K and bringing the position to 4,631 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

ALPS Advisors first reported a position in LMAT in Q1 2017 and has held it in 20 quarters since. The position peaked at $654K in Q2 2017. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

ALPS Advisors held 4,631 shares of LeMaitre Vascular worth $444K as of Q2 2026.
ALPS Advisors bought 45 LeMaitre Vascular shares in Q2 2026, an estimated $4.61K.
LeMaitre Vascular made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1023 holding.
ALPS Advisors first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 20 quarters since.
ALPS Advisors's LeMaitre Vascular position peaked at $654K in Q2 2017.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.